Mathilda Strom, Founding COO @Bioptimus | Slush 2024

At Slush 2024, our Founding COO Mathilda Strom took the stage to unveil how we at Bioptimus are building the world's first multiscale, multimodal foundation model for biology.

At Slush 2024—a founder-focused annual event delivering actionable company-building advice while bringing together the who’s who in startups and tech—our Founding COO Mathilda Strom took the stage to unveil how we at Bioptimus are building the world's first multiscale, multimodal foundation model for biology

By combining the latest revolutions in AI and advanced cell data capture (such as imaging and omics), we are building a model that understands biology holistically—from the molecular and cellular levels all the way up to tissues and complete organisms. For our partners and customers, this unlocks unprecedented possibilities across multiple industries:

Pharmaceuticals & Oncology: Run tests through our models alongside clinical trials to rapidly increase the speed and accuracy of results. Oncologists could soon predict patient responses to immunotherapy or chemotherapy in seconds, while researchers can simulate genetic activity to discover completely new drug targets.
Cosmetics & Food: Leverage our models as a baseline to design next-generation anti-aging creams or formulate new food ingredients that optimize vitamin absorption.

In her keynote, Mathilda also highlights the four key pillars that give us our competitive edge to deliver these tools to you:

World-Class Team: Our foundation is built by leading minds in AI and biology from Google DeepMind, Novartis, and top research institutions.
Unrivaled Data: Alongside a massive volume of data, we have unique access to the first spatial biology atlas developed by a consortium of the world's largest research hospitals.
Optimized Compute: Our infrastructure is designed for massive scalability and economic sustainability.
Proven Performance: In less than a year, we released our first model, H-Optimus-0, which recently outperformed all other histology foundation models on the market in an independent Harvard study.

We are fundamentally shifting the paradigm of how the world understands biology. Whether you are looking to integrate our AI into your R&D workflows or explore a data partnership, we invite you to join us on this journey.

More videos like this:

Rewriting Rare Disease R&D with Foundation Models

Join our CEO Jean-Philippe Vert on the RARECast podcast to discover how we are using foundation models to rewrite rare disease R&D and repurpose existing drugs .

Bridging the Gap: Bioptimus CEO Jean-Philippe Vert on Building the Foundational AI for Biology

In this deep-dive episode of the Empowered Paient Podcast, Jean-Philippe explains why understanding biology across all scales—from molecules to organs—is the key to unlocking the next generation of precision medicine.

AI in Healthcare: Scaling Drug Discovery & Clinical Trials

Join our Founding COO Mathilda Strom on the Startup Scaleup People podcast to explore how we are using AI to fix the 90% clinical trial failure rate. In this episode, Mathilda shares insights from her 20-year career in scaling high-impact ventures and explains why Bioptimus is a different kind of deep-tech challenge.

Inside Bioptimus: Training (and Tracking) Foundation Models for Biology

Discover how we at Bioptimus track and refine our foundation models for biology, to make them learn the language of life so they can help you accelerate drug discovery and compress development timelines.

Bioptimus COO Mathilda Strom on AI, Compute, and the Future of Biological Foundation Models

Mathilda Strom, the Founding COO at Bioptimus, shares her journey from building startups across Africa, Asia, and Latin America to helping shape one of the most ambitious AI and biology projects on the planet.

Foundation Models for Biology, Across Scales

Discover how AI foundation models are revolutionising biology and drug discovery. Jean-Philippe Vert explores the future of multiscale virtual cells.

Mathilda Strom, Founding COO @Bioptimus | Slush 2024

Slush is a founder-focused annual event delivering actionable company-building advice while bringing together the who’s who in startups and tech.

Building an AI model for Biology

Could AI unlock the secrets of biology? In this WIRED Health 2025 Startup Pitch, Zelda Mariet, Principal Research Scientist and Co-Founder of Bioptimus, introduces their groundbreaking universal AI foundation model that connects biology at every scale - from molecules to cells, tissues, and organisms.

AI Is About to Simulate Human Biology

Can AI become a universal simulator of biology, helping predict disease, improve drug success rates, and reshape how medicine is developed? A thoughtful conversation on AI, biology, and the future of medicine. From lessons learned in big tech to what it takes to build enduring platforms in TechBio, this is a considered discussion for anyone interested in where scientific discovery is heading.